Stock listing
Frankfurt:WAZ Waters Corporation Aktie
German listing (Frankfurt) of Waters Corporation · home listing NYSE:WAT
Follow Waters Corporation into a list and get an email when it puts out news.
Share price · FWB:WAZ
€413.20 EUR -9.00 (-2.1%)
Close on Nov 20, 2026
- Day range
- €413.20 – €413.20 EURNov 20, 2026
- Volume
- 1 sharesNov 20, 2026
- Market cap
- €40.57B EURAt the close on Nov 20, 2026 · price × 98.19M shares outstanding
- 52-week range
- €243.49 – €430.49 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €15,861 EURMedian day 18 shares · 19 days with no trades · last 3 months, Aug 20, 2026 – Nov 13, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:WAT · Home | $440.45 USD | -25.65 (-5.5%) | 1,353,532 | $454.35 | $455.14 | $437.54 | $466.10 | Close on Nov 20, 2026 |
| B3:WATC34 | 476.58 BRL | 0.00 (0.0%) | — | 476.58 | 476.58 | 476.58 | 476.58 | Close on Nov 19, 2026 |
| LSE:0LTI | $441.98 USD | -18.50 (-4.0%) | 849 | $453.00 | $457.77 | $441.98 | $460.48 | Close on Nov 20, 2026 |
| Dusseldorf:WAZ | €403.80 EUR | -12.60 (-3.0%) | — | €412.00 | €414.20 | €403.20 | €416.40 | Close on Nov 20, 2026 |
| Frankfurt:WAZ | €413.20 EUR | -9.00 (-2.1%) | 1 | €413.20 | €413.20 | €413.20 | €422.20 | Close on Nov 20, 2026 |
| Munich:WAZ | €412.60 EUR | -15.00 (-3.5%) | — | €414.80 | €414.80 | €412.60 | €427.60 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 13, 2026 · FWB:WAZ · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €413.43 | -9.554 | -2.3% | €413.43 | €413.43 | €413.43 | 10 | |
| €422.99 | +0.964 | +0.2% | €422.99 | €422.99 | €422.99 | 0 | |
| €422.02 | -2.251 | -0.5% | €422.02 | €422.02 | €422.02 | 21 | |
| €424.27 | +13.84 | +3.4% | €424.27 | €424.27 | €424.27 | 6 | |
| €410.43 | +6.848 | +1.7% | €410.43 | €410.43 | €410.43 | 142 | |
| €403.58 | -9.355 | -2.3% | €402.07 | €406.17 | €400.20 | 142 | |
| €412.94 | -7.031 | -1.7% | €412.94 | €412.94 | €412.94 | 184 | |
| €419.97 | +24.28 | +6.1% | €411.36 | €420.39 | €407.76 | 88 | |
| €395.68 | -17.23 | -4.2% | €395.68 | €395.68 | €395.68 | 27 | |
| €412.91 | -13.73 | -3.2% | €412.91 | €412.91 | €412.91 | 25 | |
| €426.64 | -0.929 | -0.2% | €426.48 | €426.67 | €426.43 | 80 | |
| €427.57 | +8.941 | +2.1% | €429.82 | €430.49 | €427.57 | 23 | |
| €418.63 | +15.90 | +3.9% | €417.97 | €418.66 | €417.04 | 140 | |
| €402.73 | -5.862 | -1.4% | €402.73 | €402.73 | €402.73 | 13 | |
| €408.59 | +6.531 | +1.6% | €404.64 | €412.61 | €404.00 | 166 | |
| €402.06 | -2.609 | -0.6% | €402.06 | €402.06 | €402.06 | 135 | |
| €404.67 | +3.268 | +0.8% | €404.87 | €405.60 | €403.98 | 50 | |
| €401.40 | +16.29 | +4.2% | €396.58 | €402.90 | €396.53 | 39 | |
| €385.11 | -2.044 | -0.5% | €385.11 | €385.11 | €385.11 | 0 | |
| €387.16 | -2.953 | -0.8% | €387.16 | €387.16 | €387.16 | 0 | |
| €390.11 | -6.434 | -1.6% | €390.71 | €390.84 | €387.77 | 0 | |
| €396.54 | +6.625 | +1.7% | €391.36 | €400.39 | €390.31 | 50 | |
| €389.92 | +6.391 | +1.7% | €384.14 | €392.63 | €382.51 | 17 | |
| €383.53 | -1.42 | -0.4% | €383.53 | €383.53 | €383.53 | 0 | |
| €384.95 | +1.319 | +0.3% | €384.95 | €384.95 | €384.95 | 60 | |
| €383.63 | -1.365 | -0.4% | €383.46 | €384.38 | €382.87 | 18 | |
| €384.99 | -2.077 | -0.5% | €384.93 | €385.17 | €384.53 | 226 | |
| €387.07 | -3.678 | -0.9% | €387.18 | €388.31 | €385.87 | 40 | |
| €390.75 | +10.13 | +2.7% | €392.35 | €397.58 | €389.33 | 66 | |
| €380.62 | +7.204 | +1.9% | €380.10 | €382.45 | €379.07 | 89 | |
| €373.42 | -7.052 | -1.9% | €373.42 | €373.42 | €373.42 | 20 | |
| €380.47 | -8.103 | -2.1% | €387.31 | €391.29 | €378.98 | 6 | |
| €388.57 | +2.417 | +0.6% | €388.57 | €388.57 | €388.57 | 0 | |
| €386.16 | +0.714 | +0.2% | €386.16 | €386.16 | €386.16 | 0 | |
| €385.44 | +11.50 | +3.1% | €375.36 | €385.80 | €374.98 | 36 | |
| €373.94 | +10.90 | +3.0% | €373.94 | €373.94 | €373.94 | 50 | |
| €363.05 | -5.212 | -1.4% | €363.05 | €363.05 | €363.05 | 0 | |
| €368.26 | -3.051 | -0.8% | €371.75 | €372.29 | €368.26 | 10 | |
| €371.31 | +4.931 | +1.3% | €370.62 | €374.84 | €370.39 | 16 | |
| €366.38 | -4.39 | -1.2% | €366.38 | €366.38 | €366.38 | 0 | |
| €370.77 | +1.952 | +0.5% | €370.77 | €370.77 | €370.77 | 8 | |
| €368.82 | +8.283 | +2.3% | €367.86 | €369.76 | €367.47 | 30 | |
| €360.54 | +10.09 | +2.9% | €361.13 | €361.16 | €360.54 | 36 | |
| €350.45 | -0.473 | -0.1% | €350.45 | €350.45 | €350.45 | 0 | |
| €350.92 | +7.304 | +2.1% | €350.92 | €350.92 | €350.92 | 0 | |
| €343.62 | -6.032 | -1.7% | €343.62 | €343.62 | €343.62 | 6 | |
| €349.65 | +5.245 | +1.5% | €350.05 | €351.34 | €346.68 | 91 | |
| €344.40 | -7.37 | -2.1% | €344.40 | €344.40 | €344.40 | 0 | |
| €351.77 | +4.705 | +1.4% | €351.77 | €351.77 | €351.77 | 0 | |
| €347.07 | -3.892 | -1.1% | €347.07 | €347.07 | €347.07 | 0 | |
| €350.96 | -0.311 | -0.1% | €350.96 | €350.96 | €350.96 | 60 | |
| €351.27 | +1.955 | +0.6% | €351.27 | €351.27 | €351.27 | 0 | |
| €349.32 | -6.325 | -1.8% | €348.79 | €350.25 | €347.61 | 2 | |
| €355.64 | +2.347 | +0.7% | €355.64 | €355.64 | €355.64 | 0 | |
| €353.29 | -6.505 | -1.8% | €353.29 | €353.29 | €353.29 | 138 | |
| €359.80 | -1.565 | -0.4% | €360.00 | €360.21 | €358.94 | 1 | |
| €361.36 | +7.741 | +2.2% | €351.97 | €362.79 | €351.68 | 108 | |
| €353.62 | +4.89 | +1.4% | €353.62 | €353.62 | €353.62 | 0 | |
| €348.73 | -0.808 | -0.2% | €348.73 | €348.73 | €348.73 | 0 | |
| €349.54 | +7.637 | +2.2% | €349.19 | €350.16 | €349.15 | 30 | |
| €341.90 | -11.95 | -3.4% | €341.90 | €341.90 | €341.90 | 2 | |
| €353.85 | -0.667 | -0.2% | €353.85 | €353.85 | €353.85 | 0 |
- Ticker
- Frankfurt:WAZ
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 17, 2026
Waters Corporation to Present at the 9th Annual Evercore Healthcare Conference
Latest earnings call · Nov 3, 2026
Waters (NYSE:WAT) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 3, 2026
Q3 2026 Earnings Presentation
Earnings · 30 slides
Latest news
Waters Achieves FDA 510(k) Clearance for Ready-to-Use Flow Cytometry Clinical Tests for Leukemia and Lymphoma
Nov 10, 2026
Closed €424.27 (+3.4%) on Nov 10, 2026
Waters Corporation (NYSE: WAT) Reports Third Quarter 2026 Financial Results
Nov 3, 2026
Closed €395.68 (-4.2%) on Nov 3, 2026
Waters Acquires MOBILion Systems, Bringing Advanced Ion-Mobility Separation to its Mass Spectrometry Portfolio with the Speed and Resolution AI Workflows Require for Proteomics Biomarker Discovery
Nov 3, 2026
Closed €395.68 (-4.2%) on Nov 3, 2026
Waters Launches AI-Powered Peak Integration Expanding its Suite of Premium AI Subscription Capabilities for Empower Software
Oct 28, 2026
Closed €418.63 (+3.9%) on Oct 28, 2026
Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026
Oct 23, 2026
Closed €402.06 (-0.6%) on Oct 23, 2026
Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening Option
Oct 20, 2026
Closed €385.11 (-0.5%) on Oct 20, 2026
IMU and UK Biobank to generate the world’s most detailed, large-scale picture of the human immune system for advancing research into health and disease
Oct 19, 2026
Closed €387.16 (-0.8%) on Oct 19, 2026
Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release
Oct 13, 2026
Closed €383.53 (-0.4%) on Oct 13, 2026
Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call
Oct 1, 2026
Closed €380.47 (-2.1%) on Oct 1, 2026
Waters Corporation on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 35 in the last 12 months · 54 in all · newest Nov 17, 2026 · oldest 2025
- Calls
- 27 calls with a replay · 27 with a transcript · latest Nov 3, 2026
- Decks
- 44 decks · latest Nov 3, 2026
Where Waters Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:WAT · Home listing | NYSE | United States | USD |
| gettex:WAZ | gettex | Germany | EUR |
| BMV:WAT | BMV | Mexico | MXN |
| B3:WATC34 | B3 | Brazil | BRL |
| LS Exchange:898123 | LS Exchange | Germany | EUR |
| Lang & Schwarz:898123 | Lang & Schwarz | Germany | EUR |
| LSE:0LTI | LSE | United Kingdom | USD |
| Tradegate:WAZ | Tradegate | Germany | EUR |
| BIVA:WAT | BIVA | Mexico | MXN |
| Dusseldorf:WAZ | Dusseldorf | Germany | EUR |
| Frankfurt:WAZ · This page | Frankfurt | Germany | EUR |
| Munich:WAZ | Munich | Germany | EUR |
| Milan:1WAT | Milan | Italy | EUR |
| Stuttgart:WAZ | Stuttgart | Germany | EUR |
| BOATS:WAT | BOATS | United States | USD |
| BX Swiss:WAZ | BX Swiss | Switzerland | CHF |
| Hamburg:WAZ | Hamburg | Germany | EUR |
| Hanover:WAZ | Hanover | Germany | EUR |
| VIE:WTRS | Vienna | Austria | EUR |
| Xetra:WAZ | Xetra | Germany | EUR |
Valuation
P/E 441× against a median of 32.2×: the highest of 9 Diagnostics & research services companies shown. Statements: 4 quarters to Oct 3, 2026 · price Nov 20, 2026
- Enterprise value
- $47.18B USD
- P/E
- 441×
- EV/sales
- 8.4×
- EV/EBITDA
- 49.4×
- Price/book
- 2.8×
- Gross margin
- 49.4%
- Operating margin
- 4.7%
- Net margin
- 1.8%
- Debt to equity
- 0.3×
- Beta vs S&P 500
- 0.97
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Waters Corporation · NYSE:WAT | US$43.29B | US$47.18B | 441× | 8.4× | 49.4× | 2.8× | 1.8% | 0.3× | 0.97 |
| Lonza Group AG · SIX:LONN | US$54.17B | US$58.55B | 47.9× | 7.5× | 26.1× | 5.6× | 14.5% | 0.5× | n/a |
| IDEXX Laboratories, Inc. · NASDAQ:IDXX | US$53.28B | US$53.45B | 45.1× | 11.5× | n/a | 28.5× | 25.4% | 0.2× | 0.77 |
| WuXi AppTec Co., Ltd. Class A · SSE:603259 | US$52.27B | US$44.51B | 13.2× | 5.1× | n/a | 3.6× | 45.5% | 0.0× | n/a |
| Agilent Technologies, Inc. · NYSE:A | US$48.04B | US$50.23B | 33.4× | 6.8× | n/a | 6.5× | 19.5% | 0.5× | 0.87 |
| Samsung Biologics Co., Ltd. · KRX:207940 | US$46.86B | US$45.66B | 31.8× | 13.5× | 22.2× | 7.5× | 43.6% | 0.1× | n/a |
| IQVIA Holdings, Inc. · NYSE:IQV | US$40.51B | US$54.16B | 29.1× | 3.1× | 15.8× | 6.1× | 8.1% | 2.4× | 0.70 |
| Natera, Inc. · NASDAQ:NTRA | US$39.64B | US$38.79B | n/a | 13.3× | n/a | 21.2× | −5.7% | 0.1× | 1.34 |
| Illumina, Inc. · NASDAQ:ILMN | US$29.15B | US$27.82B | 32.6× | n/a | n/a | 9.3× | n/a | 0.0× | 1.14 |
| Wuxi Biologics (Cayman) Inc. · HKEX:2269 | US$21.51B | US$19.96B | 29.2× | 6.1× | 15.9× | 3.0× | 22.5% | 0.1× | n/a |
| Guardant Health, Inc. · NASDAQ:GH | US$19.73B | US$20.20B | n/a | 15.8× | n/a | n/a | −37.9% | n/a | 1.16 |
| Median of the others | US$43.69B | US$45.09B | 32.2× | 7.5× | 19.0× | 6.5× | 19.5% | 0.1× | 1.00 |
Forecasts
15 strong buy · 3 buy · 5 hold · 1 sell · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.
- Price target
- 503.29 USD · Analysts' mean
- EPS, year to Dec 2026
- 14.67 · 23 analysts
- Revenue, year to Dec 2026
- 6.49B · 21 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Fraser McLeod | Chief Executive Officer |
| Amol Chaubal | SVP & Chief Financial Officer |
| Pearl S. Huang | President, Dunad Therapeutics |
| Udit Batra | President |
| Keeley Aleman | SVP, General Counsel and Head of Global Human Resources |
| Caspar Tudor | Head of Investor Relations |
| Allan Jaenicke | SVP, Transformation |
| Brook Colangelo | SVP & Chief Information Officer |
| Daniel Rush | SVP, Global Research & Strategy |
| Jianqing Bennett | SVP, Waters Advanced Diagnostics Division |
| Joyce Yoon | SVP, Waters Materials Sciences Division |
| Kristen Garvey | SVP, Global Communications |
| Mark Gladwell | SVP, Global Operations |
| Steve Conly | SVP, Waters Biosciences Division |
| Tina Wu | SVP, Waters Analytical Sciences Division |
Board
| Director | Role |
|---|---|
| Flemming Ørnskov | Chair of the Board |
| Claire M. Fraser | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Waters (NYSE:WAT) Q3 2026 Earnings Call | Tue, Nov 03, 2026 · 8:00 AM ET | Replay |
| Waters (NYSE:WAT) Q2 2026 Earnings Call | Tue, Aug 04, 2026 · 8:00 AM ET | Replay |
| Waters (NYSE:WAT) Q1 2026 Earnings Call | Tue, May 05, 2026 · 8:30 AM ET | Replay |
| Waters (NYSE:WAT) Q4 2025 Earnings Call | Mon, Feb 09, 2026 · 8:30 AM ET | Replay |
| Waters (NYSE:WAT) Q3 2025 Earnings Call | Tue, Nov 04, 2025 · 8:00 AM ET | Replay |
| Waters (NYSE:WAT) Q2 2025 Earnings Call | Mon, Aug 04, 2025 · 8:00 AM ET | Replay |
| Waters (NYSE:WAT) Q1 2025 Earnings Call | Tue, May 06, 2025 · 8:00 AM ET | Replay |
| Waters (NYSE:WAT) Q4 2024 Earnings Call | Wed, Feb 12, 2025 · 8:00 AM ET | Replay |
| Waters (NYSE:WAT) Q3 2024 Earnings Call | Fri, Nov 01, 2024 · 8:00 AM ET | Replay |
| Waters (NYSE:WAT) Q2 2024 Earnings Call | Wed, Jul 31, 2024 · 8:00 AM ET | Replay |
All 27 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 3, 2026 · Before open | +2.3% |
| Q2 2026 | Aug 4, 2026 · Before open | +5.7% |
| Q1 2026 | May 5, 2026 · Before open | +13.5% |
| Q4 2025 | Feb 9, 2026 · Before open | −13.9% |
| Q3 2025 | Nov 4, 2025 · Before open | +6.3% |
| Q2 2025 | Aug 4, 2025 · Before open | −1.6% |
| Q1 2025 | May 6, 2025 · Before open | −2.7% |
| Q4 2024 | Feb 12, 2025 · Before open | −5.8% |
| Q3 2024 | Nov 1, 2024 · Before open | +19.8% |
| Q2 2024 | Jul 31, 2024 · Before open | +2.6% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 7, 2024 · Before open | +1.9% |
| Q4 2023 | Feb 6, 2024 · Before open | +1.7% |
| Q3 2023 | Nov 7, 2023 · Before open | +3.4% |
| Q2 2023 | Aug 2, 2023 · Before open | +6.3% |
| Q1 2023 | May 9, 2023 · Before open | −6.7% |
| Q4 2022 | Feb 15, 2023 · Before open | −0.7% |
| Q3 2022 | Nov 1, 2022 · Before open | +2.8% |
| Q2 2022 | Aug 2, 2022 · Before open | −6.8% |
| Q1 2022 | May 3, 2022 · Before open | +8.1% |
| Q4 2021 | Feb 1, 2022 · Before open | +1.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 30 slides | Nov 3, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 33 slides | Aug 4, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 29 slides | May 5, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 22 slides | Feb 9, 2026 |
| J.P. Morgan 44th Annual Healthcare Conference (January 2026) | Conference | 29 slides | Jan 12, 2026 |
| J.P. Morgan 43rd Annual Healthcare Conference (November 2025) | Conference | 38 slides | Nov 11, 2025 |
| Q3 2025 Earnings Presentation | Earnings | 18 slides | Nov 4, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 21 slides | Aug 4, 2025 |
| Merger or Acquisition (July 2025) | Merger or acquisition | 24 slides | Jul 14, 2025 |
| Merger or Acquisition (July 2025) | Merger or acquisition | 36 slides | Jul 14, 2025 |
All 44 decks
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.17B | 2.96B | 2.96B | 2.97B | 2.79B | 2.37B | 2.41B | 2.42B | 2.31B | 2.17B |
| Cost of revenue | 1.29B | 1.20B | 1.20B | 1.25B | 1.16B | 1.01B | 1.01B | 992.6M | 947.1M | 891.5M |
| Gross profit | 1.83B | 1.76B | 1.76B | 1.72B | 1.63B | 1.36B | 1.40B | 1.43B | 1.36B | 1.28B |
| Research and development | 195.7M | 183.0M | 174.9M | 176.2M | 168.4M | 140.8M | 143.0M | 143.4M | 132.6M | 125.2M |
| Selling, general and administrative | 830.4M | 690.1M | 736.0M | 658.0M | 627.0M | 553.7M | 534.8M | 536.9M | 544.4M | 512.3M |
| Operating income | 802.6M | 826.4M | 817.7M | 873.4M | 821.7M | 645.5M | 708.5M | 739.8M | 662.2M | 625.0M |
| Depreciation and amortization | 88.1M | 87.0M | 84.6M | 72.0M | 71.6M | 68.7M | 53.8M | 58.0M | 61.5M | 51.7M |
| EBITDA | 890.7M | 913.4M | 902.3M | 945.4M | 893.3M | 714.2M | 762.3M | 797.7M | 723.6M | 676.7M |
| Interest expense | 69.5M | 89.7M | 98.9M | 48.8M | 44.9M | 49.1M | 48.7M | 48.6M | 56.8M | 44.9M |
| Income before tax | 754.9M | 754.9M | 736.2M | 837.8M | 806.2M | 610.9M | 678.2M | 682.1M | 641.1M | 600.1M |
| Income tax | 112.2M | 117.0M | 94.0M | 130.1M | 113.3M | 89.3M | 86.0M | 88.4M | 620.8M | 78.6M |
| Net income | 642.6M | 637.8M | 642.2M | 707.8M | 692.8M | 521.6M | 592.2M | 593.8M | 20.3M | 521.5M |
| Earnings per share, basic | 10.80 | 10.75 | 10.87 | 11.80 | 11.25 | 8.40 | 8.76 | 7.71 | 0.25 | 6.46 |
| Earnings per share, diluted | 10.76 | 10.71 | 10.84 | 11.73 | 11.17 | 8.36 | 8.69 | 7.65 | 0.25 | 6.41 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 588.0M | 325.4M | 395.1M | 480.5M | 501.2M | 436.7M | 335.7M | 796.3M | 642.3M | 505.6M |
| Short-term investments | 934.0K | 898.0K | 862.0K | 68.1M | 6.45M | 1.43M | 938.9M | 2.75B | 2.31B | |
| Receivables | 829.0M | 733.4M | 702.2M | 722.9M | 612.6M | 573.3M | 587.7M | 568.3M | 533.8M | 489.3M |
| Inventory | 572.0M | 477.3M | 516.2M | 455.7M | 356.1M | 304.3M | 320.6M | 291.6M | 270.3M | 262.7M |
| Current assets | 2.15B | 1.67B | 1.75B | 1.76B | 1.63B | 1.40B | 1.31B | 2.66B | 4.27B | 3.64B |
| Property, plant and equipment | 642.0M | 651.2M | 639.1M | 582.2M | 547.9M | 494.0M | 417.3M | 343.1M | 349.3M | 337.1M |
| Goodwill | 1.34B | 1.30B | 1.31B | 430.3M | 437.9M | 444.4M | 356.1M | 355.6M | 359.8M | 352.1M |
| Total assets | 5.08B | 4.55B | 4.63B | 3.28B | 3.09B | 2.84B | 2.56B | 3.73B | 5.32B | 4.66B |
| Accounts payable | 104.0M | 99.9M | 84.7M | 93.3M | 96.8M | 72.2M | 49.0M | 68.2M | 64.5M | 67.7M |
| Current liabilities | 1.24B | 789.8M | 789.6M | 785.7M | 680.5M | 805.0M | 591.3M | 448.9M | 606.2M | 520.3M |
| Long-term debt | 947.0M | 1.63B | 2.31B | 1.52B | 1.51B | 1.21B | 1.58B | 1.15B | 1.90B | 1.70B |
| Total debt | 1.41B | 1.63B | 2.36B | 1.58B | 1.52B | 1.36B | 1.69B | 1.15B | 1.90B | 1.83B |
| Total liabilities | 2.52B | 2.73B | 3.48B | 2.78B | 2.73B | 2.61B | 2.77B | 2.16B | 3.09B | 2.36B |
| Shareholders' equity | 2.56B | 1.83B | 1.15B | 504.5M | 367.6M | 232.1M | -216.3M | 1.57B | 2.23B | 2.30B |
| Shares outstanding | 59.5M | 59.4M | 59.2K | 59.1M | 60.7M | 62.3M | 62.6M | 73.1M | 79.3M | 80.0M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 652.6M | 762.1M | 602.8M | 611.7M | 747.3M | 790.5M | 643.1M | 604.4M | 697.6M | 642.9M |
| Capital spending | -112.7M | -142.5M | -160.6M | -183.5M | -168.3M | -172.4M | -163.8M | -127.6M | -90.5M | -95.0M |
| Free cash flow | 539.8M | 619.6M | 442.2M | 428.2M | 579.0M | 618.1M | 479.3M | 476.9M | 607.2M | 534.1M |
| Cash from investing | -152.3M | -143.1M | -1.44B | -108.0M | -231.6M | -264.1M | 768.8M | 1.68B | -535.8M | -487.9M |
| Cash from financing | -237.2M | -696.7M | 755.0M | -509.6M | -438.3M | -440.5M | -1.87B | -2.12B | -63.9M | -115.7M |
| Dividends paid | -1.56B | -42.8M | -55.6M | -66.0M | -53.7M | 0 | 0 | |||
| Share buybacks | -14.7M | -13.5M | -70.3M | -626.1M | -648.9M | -196.4M | -2.47B | -1.32B | -332.5M | -325.8M |
| Change in cash | 262.5M | -69.7M | -85.5M | -20.7M | 64.5M | 101.0M | -460.6M | 154.0M | 136.7M | 18.0M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 16, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 10, 2026 | Quarterly report | SEC |
| 3 · Initial statement of ownership | Nov 6, 2026 | Insider trade | SEC |
| 8-K · Current report | Nov 3, 2026 | Results | SEC |
| 4 · Change in ownership | Oct 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 31, 2026 | Insider trade | SEC |
| 8-K · Current report | Aug 21, 2026 | Management or board change | SEC |
| 10-Q · Quarterly report | Aug 11, 2026 | Quarterly report | SEC |
| 4 · Change in ownership | Aug 7, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 144 · Notice of proposed sale | Aug 6, 2026 | Other filings | SEC |
| 8-K · Current report | Aug 4, 2026 | Results | SEC |
| 4 · Change in ownership | Jul 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 25, 2026 | Insider trade | SEC |
| 11-K · Annual report of an employee plan | Jun 25, 2026 | Annual report | SEC |
| SD · Specialized disclosure | May 29, 2026 | ESG report | SEC |
| 8-K · Current report | May 22, 2026 | Meeting outcome | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | May 14, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 12, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 5, 2026 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 30, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 24, 2026 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Apr 9, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 9, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 9, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Mar 23, 2026 | Material contract | SEC |
| 424B2 · Prospectus | Mar 19, 2026 | Offer document | SEC |
| 4 · Change in ownership | Mar 18, 2026 | Insider trade | SEC |
| FWP · Free writing prospectus | Mar 17, 2026 | Offer document | SEC |
| 424B2 · Prospectus | Mar 16, 2026 | Offer document | SEC |
| S-3ASR · Registration statement | Mar 16, 2026 | Offer document | SEC |
| 8-K · Current report | Mar 16, 2026 | Current report | SEC |
| 4 · Change in ownership | Mar 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Feb 23, 2026 | Offer document | SEC |
| 10-K · Annual report | Feb 23, 2026 | Annual report | SEC |
| 3 · Initial statement of ownership | Feb 18, 2026 | Insider trade | SEC |
| 8-K · Current report | Feb 9, 2026 | Acquisition or disposal | SEC |
| 8-K · Current report | Feb 9, 2026 | Results | SEC |
| 4 · Change in ownership | Feb 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 6, 2026 | Insider trade | SEC |
| 8-K · Current report | Jan 27, 2026 | Meeting outcome | SEC |
| 425 | Jan 16, 2026 | Other filings | SEC |
| 8-K · Current report | Jan 16, 2026 | Current report | SEC |
| 425 | Jan 13, 2026 | Other filings | SEC |
| 425 | Jan 12, 2026 | Other filings | SEC |
| 8-K · Current report | Jan 12, 2026 | Current report | SEC |
| 425 | Jan 12, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 425 | Jan 5, 2026 | Other filings | SEC |
| EFFECT · Notice that a registration is effective | Dec 29, 2025 | Other filings | SEC |
| 424B3 · Prospectus | Dec 23, 2025 | Offer document | SEC |
| S-4/A · Registration statement, amended | Dec 19, 2025 | Offer document | SEC |
| 425 | Dec 15, 2025 | Other filings | SEC |
| S-4 · Registration statement | Dec 11, 2025 | Offer document | SEC |
| 425 | Nov 18, 2025 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 14, 2025 | Big-stake notice | SEC |
| 425 | Nov 10, 2025 | Other filings | SEC |
| 425 | Nov 10, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 7, 2025 | Insider trade | SEC |
| 425 | Nov 4, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 4, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 4, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 31, 2025 | Big-stake notice | SEC |
| 425 | Oct 14, 2025 | Other filings | SEC |
| 4 · Change in ownership | Oct 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2025 | Insider trade | SEC |
| 425 | Sep 16, 2025 | Other filings | SEC |
| 425 | Sep 4, 2025 | Other filings | SEC |
| 425 | Aug 28, 2025 | Other filings | SEC |
| 425 | Aug 21, 2025 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 13, 2025 | Big-stake notice | SEC |
| 425 | Aug 4, 2025 | Other filings | SEC |
| 425 | Aug 4, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 4, 2025 | Quarterly report | SEC |
| 425 | Aug 4, 2025 | Other filings | SEC |
| 8-K · Current report | Aug 4, 2025 | Results | SEC |
| 425 | Jul 21, 2025 | Other filings | SEC |
| 425 | Jul 14, 2025 | Other filings | SEC |
| 425 | Jul 14, 2025 | Other filings | SEC |
| 425 | Jul 14, 2025 | Other filings | SEC |
| 425 | Jul 14, 2025 | Other filings | SEC |
| 425 | Jul 14, 2025 | Other filings | SEC |
| 425 | Jul 14, 2025 | Other filings | SEC |
| 425 | Jul 14, 2025 | Other filings | SEC |
| 425 | Jul 14, 2025 | Other filings | SEC |
| 425 | Jul 14, 2025 | Other filings | SEC |
| 425 | Jul 14, 2025 | Other filings | SEC |
| 425 | Jul 14, 2025 | Other filings | SEC |
| 8-K · Current report | Jul 14, 2025 | Material contract | SEC |
| 425 | Jul 14, 2025 | Other filings | SEC |
| 425 | Jul 14, 2025 | Other filings | SEC |
| 8-K · Current report | Jul 14, 2025 | Current report | SEC |
| 4 · Change in ownership | Jul 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 26, 2025 | Insider trade | SEC |
| 11-K · Annual report of an employee plan | Jun 24, 2025 | Annual report | SEC |
| S-8 · Registration statement for employee plans | Jun 13, 2025 | Offer document | SEC |
| SD · Specialized disclosure | May 30, 2025 | ESG report | SEC |
| 8-K · Current report | May 29, 2025 | Material contract | SEC |
| 8-K · Current report | May 23, 2025 | Meeting outcome | SEC |
| SCHEDULE 13G · Big-stake notice | May 14, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | May 14, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | May 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 6, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 17, 2025 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Apr 9, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 9, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 9, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 10-K · Annual report | Feb 25, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 12, 2025 | Results | SEC |
| 4 · Change in ownership | Feb 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 7, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 13, 2025 | Current report | SEC |
| 4 · Change in ownership | Jan 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 12, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 7, 2024 | Big-stake notice | SEC |
| 8-K/A · Current report, amended | Nov 1, 2024 | Management or board change | SEC |
| 10-Q · Quarterly report | Nov 1, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 1, 2024 | Results | SEC |
| 4/A · Change in ownership, amended | Oct 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 15, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 15, 2024 | Insider trade | SEC |
| 8-K · Current report | Aug 14, 2024 | Management or board change | SEC |
| 10-Q · Quarterly report | Jul 31, 2024 | Quarterly report | SEC |
| 8-K · Current report | Jul 31, 2024 | Results | SEC |
| 8-K · Current report | Jul 18, 2024 | Material contract | SEC |
| 4 · Change in ownership | Jul 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 25, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 25, 2024 | Insider trade | SEC |
| 11-K · Annual report of an employee plan | Jun 20, 2024 | Annual report | SEC |
| SC 13G/A · Big-stake notice, amended | Jun 10, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | May 29, 2024 | Insider trade | SEC |
| SD · Specialized disclosure | May 28, 2024 | ESG report | SEC |
| 8-K · Current report | May 24, 2024 | Meeting outcome | SEC |
| 4 · Change in ownership | May 16, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 15, 2024 | Other filings | SEC |
| 4 · Change in ownership | May 14, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | May 7, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 7, 2024 | Results | SEC |
| ARS · Annual report to shareholders | Apr 12, 2024 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 12, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 12, 2024 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 8, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2024 | Insider trade | SEC |
This page holds 200 of 1,000 filings. Open Filings
Cap table
Built by 6ix from Waters Corporation’s releases · as of Nov 6, 2026
- Common shares
- 98,285,634
- Fully diluted
- 98,285,634
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 98,285,634 | Nov 6, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 6, 2026 | 98,285,634 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Richard H. Fearon Other companies: CRH PLC (Non-management Director · Since at least Jan 1, 2025); Crown Holdings, Inc. (Director · Since at least Dec 13, 2019); Avient Corporation (Non-Executive Chairman · Since at least Dec 30, 2005); Hennessy Capital Investment Corp VI (Director · Sep 28, 2021 – Mar 27, 2023 · Past); Eaton Corporation, PLC (See Remarks below., Director · Feb 21, 2006 – Mar 4, 2021 · Past) | Director · Since at least Mar 27, 2023 |
| Daniel Brennan Other companies: Crinetics Pharmaceuticals, Inc. (Member of the Board of Directors · Since at least Nov 4, 2026); Vertex Pharmaceuticals Incorporated (Director · Since at least Oct 20, 2026); Madrigal Pharmaceuticals, Inc. (Director · Since at least Aug 1, 2025); Boston Scientific Corporation (EVP and CFO · Jan 1, 2023 – Feb 18, 2025 · Past) | Director · Since at least Nov 23, 2022 |
| Gary Hendrickson Other companies: James Hardie Industries plc. (Independent, Non-Executive Director · Since at least Mar 17, 2026); Azek Company Inc (Director · Since at least Jun 11, 2020); Polaris Inc. (Director · Since at least Apr 28, 2011); Stepan Company (Director · Apr 21, 2009 – Jul 29, 2011 · Past) | Director · Sep 1, 2018 – May 5, 2022 · Past |
| Mark P. Vergnano Other companies: Johnson Controls International plc (Chairman of the Board; Retired Chief Executive Officer and Chairman, The Chemours Company · Since at least Sep 2, 2016); Chemours Company (the) (Director · Jun 17, 2015 – Mar 1, 2022 · Past); EIDP, Inc. USD 3.50 (Executive Vice President · Apr 29, 2010 – Jun 12, 2015 · Past) | Director · Since at least Nov 23, 2022 |
| Sherry L. Buck Other companies: Ball Corporation (Director · Since at least Sep 21, 2026); Lennox International, Inc. (Director · Since at least Jul 12, 2019); Libbey Inc (Vice President, CFO · Aug 1, 2012 – Aug 1, 2016 · Past) | SVP and CFO · Jan 9, 2017 – Oct 30, 2020 · Past |
| Belinda Hyde Other companies: Sealed Air Corporation (Chief People Officer · Since at least Sep 9, 2024); SPX FLOW Inc (VP and CHRO · Jan 10, 2020 – Dec 22, 2020 · Past) | SVP, Global Human Resources · Jan 11, 2021 – Feb 17, 2022 · Past |
| Claire M. Fraser Other companies: Seres Therapeutics, Inc. (Director · Since at least Jan 4, 2023); Becton, Dickinson and Company (Director · Since at least Nov 20, 2006) | Director · Since at least Feb 9, 2026 |
| Edward Conard Other companies: Sensata Technologies Holding plc (Director · Mar 10, 2010 – Mar 10, 2011 · Past); Innophos Holdings Inc (Director · Nov 2, 2006 – Nov 9, 2006 · Past) | Director · Jan 3, 2006 – Mar 31, 2023 · Past |
| Heather Knight Other companies: Solventum Corporation (Chief Commercial Officer · Since at least Oct 21, 2025); Baxter International Inc. (EVP, Chief Operating Officer · Mar 1, 2023 – Mar 6, 2025 · Past) | Director · Since at least Aug 14, 2024 |
| Joann A Reed Other companies: American Tower Corporation (REIT) (Director · Mar 10, 2017 – Mar 10, 2025 · Past); Mallinckrodt Inc (Director · Jul 21, 2016 – Jun 16, 2022 · Past) | Director · Jan 4, 2016 – Mar 5, 2021 · Past |
All 52 people
| Person | Seat |
|---|---|
| John M Ballbach Other companies: RPM International Inc. (Director · Jun 27, 2018 – Oct 31, 2023 · Past); Timken Company (the) (Director · May 8, 2012 – May 7, 2013 · Past) | Director · Oct 5, 2021 – Jan 3, 2022 · Past |
| Linda Baddour Other companies: CryoPort, Inc. (Board Member · Since at least Mar 15, 2021); PRA Health Sciences Inc (Executive VP & CFO · Nov 12, 2014 – Jan 16, 2018 · Past) | Director · Since at least Sep 1, 2018 |
| Amol Chaubal Other companies: Quanterix Corporation (Chief Financial Officer · Apr 12, 2019 – May 3, 2021 · Past) | SVP & Chief Financial Officer · Since at least May 12, 2021 |
| Daniel J Welch Other companies: Evergreen Solar Inc (VP and GM - US Manufacturing · Sep 30, 2010 – Mar 1, 2011 · Past) | SVP Global Operations · Jul 9, 2020 – Feb 23, 2022 · Past |
| John A Ornell Other companies: Bruker Corporation (Director · Since at least Aug 19, 2015) | CFO · Aug 6, 2010 – Dec 6, 2013 · Past |
| Jonathan M Pratt Other companies: SPX FLOW Inc (Director · Aug 20, 2020 – Apr 5, 2022 · Past) | SVP Waters Division · Sep 3, 2019 – Oct 10, 2023 · Past |
| Laurie H M D Glimcher Other companies: Analog Devices, Inc. (Director · Aug 18, 2020 – Mar 12, 2025 · Past) | Director · Nov 1, 2019 – Jan 2, 2020 · Past |
| Michael J Berendt Other companies: Retension Pharmaceuticals, Inc. (Director · Since at least Oct 13, 2026) | Director · May 15, 2013 – Aug 13, 2021 · Past |
| Thomas P. Salice Other companies: Mettler-Toledo International, Inc. (Director · Since at least Jun 5, 2019) | Director · Nov 1, 2019 – Jan 3, 2022 · Past |
| Wei Jiang Other companies: STAAR Surgical Company (Director · Since at least Mar 12, 2024) | Director · Since at least Jul 14, 2021 |
| Allan Jaenicke | SVP, Transformation · Since at least Nov 5, 2026 |
| Arthur G Caputo | EVP and President, Waters Div · Dec 31, 2005 – Dec 6, 2016 · Past |
| Brian K Mazar | SVP · Dec 31, 2005 – Dec 31, 2005 · Past |
| Brook Colangelo | SVP & Chief Information Officer · Since at least Nov 5, 2026 |
| Caspar Tudor | Head of Investor Relations · Since at least Nov 3, 2026 |
| Christopher A. Kuebler | Director · Since at least Jan 2, 2024 |
| Christopher J OConnell | CEO and President · Dec 5, 2017 – Jul 31, 2020 · Past |
| Dan Brennan | Since at least Nov 4, 2026 |
| Daniel Rush | SVP, Global Research & Strategy · Since at least Nov 5, 2026 |
| David Terricciano | SVP, Global Operations · Feb 10, 2016 – Feb 28, 2018 · Past |
| Elizabeth B Rae | SVP, Global HR · May 23, 2006 – Aug 20, 2020 · Past |
| Flemming Ornskov | Director · Since at least Jun 22, 2017 |
| Flemming Ørnskov | Chair of the Board · Since at least Feb 9, 2026 |
| Francis Kim | SVP Global Operations · Mar 19, 2018 – Mar 2, 2020 · Past |
| Fraser McLeod | Chief Executive Officer · Since at least Mar 10, 2026 |
| Ian King | SVP, Global Products · Feb 10, 2016 – Mar 1, 2021 · Past |
| Janice Foley | Senior Public Relations Manager, Corporate Communications · Apr 1, 2025 – Nov 4, 2026 · Past |
| Jianqing Bennett | SVP, Waters Advanced Diagnostics Division · Since at least May 1, 2021 |
| Joyce Yoon | SVP, Waters Materials Sciences Division · Since at least Nov 5, 2026 |
| Keeley Aleman | SVP, General Counsel and Head of Global Human Resources · Since at least Oct 12, 2020 |
| Kristen Garvey | SVP, Global Communications · Since at least Nov 5, 2026 |
| Mark Gladwell | SVP, Global Operations · Since at least Nov 5, 2026 |
| Mark T Beaudouin | SVP and General Counsel · Dec 5, 2017 – Nov 15, 2019 · Past |
| Michael C Harrington | SVP, Global Markets · Dec 5, 2017 – Mar 1, 2021 · Past |
| Michael F Silveira | VP, Corporate Controller · Aug 23, 2013 – May 3, 2022 · Past |
| Pearl S. Huang | President, Dunad Therapeutics · Since at least Jan 1, 2021 |
| Robert L Carpio III | SVP Waters Analytical Sciences · Since at least Jun 24, 2024 |
| Rohit Khanna | SVP, Applied Technology · Feb 10, 2016 – Dec 29, 2017 · Past |
| Steve Conly | SVP, Waters Biosciences Division · Since at least Oct 19, 2026 |
| Tina Wu | SVP, Waters Analytical Sciences Division · Since at least Oct 28, 2026 |
| Tong Wu | SVP Waters Analytical Sciences · Since at least Aug 21, 2026 |
| Udit Batra | President · Since at least Sep 1, 2020 |
Log in to ask 6ix AI your own questions about Waters Corporation.